1 / 9

Sattar N, et al. Lancet 2010;375:735-42

Sattar N, et al. Lancet 2010;375:735-42. Flow diagram of literature search to identify randomised placebo-controlled and standard care-controlled statin trials. Sattar N, et al. Lancet 2010;375:735-42.

vaughan-mckenzie
Download Presentation

Sattar N, et al. Lancet 2010;375:735-42

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Sattar N, et al. Lancet 2010;375:735-42

  2. Flow diagram of literature search to identify randomised placebo-controlled and standard care-controlled statin trials Sattar N, et al. Lancet 2010;375:735-42

  3. Association between statin therapy and incident diabetes in 13 major cardiovascular trials† Sattar N, et al. Lancet 2010;375:735-42

  4. Data for non-diabetic participants in 13 placebo-controlled and standard care-controlled statin trials that reported incident diabetes DM=diabetes mellitus. CVD=cardiovascular disease. CHD=coronary heart disease. OGTT=oral glucose tolerance test. MI=myocardial infarction. NYHA=New York Heart Association. BMI=body-mass index. FPG=fasting plasma glucose. *Diff erence between the groups in the change from baseline to timepoint in LDL-C. †Data from total cohort (including diabetes at baseline). ‡Median. §Includes only patients with normal fasting glycaemia at baseline. ||Weighted mean follow-up. Sattar N, et al. Lancet 2010;375:735-42

  5. Association between different statins and development of diabetes Sattar N, et al. Lancet 2010;375:735-42

  6. Meta-regression of (A) baseline age, (B) baseline BMI, and (C) on-treatment percentage reduction in LDL-cholesterol concentration for incident diabetes Meta-regression p=0.019 (A), p=0.177 (B), p=0.102 (C). Sattar N, et al. Lancet 2010;375:735-42

  7. Meta-regression of baseline age percentage reduction in LDL-cholesterol concentration for incident diabetes Sattar N, et al. Lancet 2010;375:735-42

  8. Meta-regression of baseline BMI percentage reduction in LDL-cholesterol concentration for incident diabetes Sattar N, et al. Lancet 2010;375:735-42

  9. Meta-regression of on-treatment percentage reduction in LDL-cholesterol concentration for incident diabetes Sattar N, et al. Lancet 2010;375:735-42

More Related